Advertisement

Topics

Cognis Corp. Company Profile

06:24 EDT 24th September 2017 | BioPortfolio

Globally, Cognis is a leading specialty chemicals company. With a strong management board formation and a streamlined organizational structure Cognis is well on the way to write the next chapter of its success story. Utilizing its 160 years of experience in oleochemicals, Cognis develops innovative products and solutions for personal care, home care and modern nutrition, as well as high-performance products for numerous industrial markets in the four strategic business units: Care Chemicals, Nutrition & Health, Functional Products, and Process Chemicals.

Cognis Oleochemicals is one of the world's leading global Oleochemicals suppliers.

Cognis chemistry is already profiting from having met the highest requirements in relation to sustainability and environmental compatibility. Moreover, the worldwide wellness trend is generating increasing demand for products, formulations and marketing concepts from us as the global market leader in the personal care sector. Enjoying a similar success are our commodities and active ingredients for dietary supplements and the health market. Cognis combines specialty chemical competence with marketing know-how to create ambitious offerings for its customers – always focused on the end consumer and always closely in tune with the industrial process.

Location

5051 Estecreek Drive
Cincinnati
Ohio
45232-1446
United States of America

Contact

Phone: 1-513-482-3000
Fax: 1-513-482-5503


News Articles [43 Associated News Articles listed on BioPortfolio]

Helix BioPharma Corp. Director Resigns

TORONTO, ONTARIO -- (Marketwired) -- 07/17/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the...

GTX Corp Receives Military Contract

LOS ANGELES, CALIFORNIA , Sept. 20, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive ...

GTX Corp Partners with ORBCOMM to Enable GPS SmartSoles on the Verizon Network

LOS ANGELES, CALIFORNIA , Sept. 12, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive te...

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, tod...

Zomedica Pharmaceuticals Corp. Amends Quorum Requirement for Shareholder Meetings

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) ("Zomedica" or the "Company"), a veterinary pharmaceutical and health care solutions company, today...

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will presen...

Orkla Food Ingredients signs licence agreement with Renaissance BioScience Corp. for Acrylamide-Reducing Yeast Technology

OSLO, Norway and VANCOUVER, British Columbia, May 23, 2017 (GLOBE NEWSWIRE) -- Orkla Food Ingredients, a business area of Orkla ASA (OSE:ORK) has signed a licence agreement with Renaissance BioSc...

pSivida Corp. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Monday, September 11th

WATERTOWN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for treating eye dise...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.

Electric conductivity in plasma is the balance between oxidized and reduced molecules (static Oxidation-Reduction Potential, sORP) and the amount of readily oxidizable molecules (capacity ORP, cORP). ...

Variations in Oxidative Stress Levels in 3 Days Follow-up in Ultramarathon Mountain Race Athletes.

Spanidis, Y, Stagos, D, Orfanou, M, Goutzourelas, N, Bar-or, D, Spandidos, D, and Kouretas, D. Variations in oxidative stress levels in 3 days follow-up in ultramarathon mountain race athletes. J Stre...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following

The COGENT-4 Field Following Study will evaluate the clinical performance of the Boston Scientific TELIGEN 100 HE Implantable Cardioverter Defibrillator (ICD), the COGNIS 100 HE Cardiac Re...

The 4-SITE Field Following Study (4-SITE FF)

The purpose of this study is to evaluate and document appropriate clinical performance of the new 4-SITE Header / Lead interface in the TELIGEN 100 HE 4-SITE (VR and DR) implantable cardio...

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [44 Associated Companies listed on BioPortfolio]

BASF

Cognis was created in 1999 from the chemicals business of Henkel, one of the leading German producers of consumer goods. Since November 2001, Cognis has been owned by Cognis Holding Luxembourg S.a r.l...

Cognis

Cognis (www.cognis.com) is a worldwide supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company empl...

Cognis Austria

Globally, Cognis is a leading specialty chemicals company. With a strong management board formation and a streamlined organizational structure Cognis is well on the way to write the next chapter of ...

Cognis Corp.

Globally, Cognis is a leading specialty chemicals company. With a strong management board formation and a streamlined organizational structure Cognis is well on the way to write the next chapter of ...

Cognis Nutrition and Health

More Information about "Cognis Corp." on BioPortfolio

We have published hundreds of Cognis Corp. news stories on BioPortfolio along with dozens of Cognis Corp. Clinical Trials and PubMed Articles about Cognis Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cognis Corp. Companies in our database. You can also find out about relevant Cognis Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record